Hemostasis Today

April, 2026
April 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
Laura Dormer: Real-World Insights into Treatment and Costs in VWD from FORvWARD Study
Apr 13, 2026, 13:07

Laura Dormer: Real-World Insights into Treatment and Costs in VWD from FORvWARD Study

Laura Dormer, Co-Founder and Editorial Director at Becaris Publishing, shared on LinkedIn about a recent article by Benoit Polack et al, adding:

”New Research Article published in the Journal of Comparative Effectiveness Research

‘Real-word evidence on healthcare resource use and associated costs in on-demand users of replacement therapies in von Willebrand disease in France: the FORvWARD study’

Using the French national healthcare claims database, the FORvWARD study examines treatment patterns, healthcare resource use and associated costs among adults with von Willebrand disease using on-demand replacement therapies.

This real-world analysis offers valuable insight into resource use in a rare bleeding disorder and highlights the role of national claims data in comparative treatment evaluation.”

Title: Real-word evidence on healthcare resource use and associated costs in on-demand users of replacement therapies in von Willebrand disease in France: the FORvWARD study

Authors: Benoit Polack, Virginie Nerich, Claire Marant Micallef, Marc Trossaërt, Christine Biron-Andreani, Nadège Bornier, Catherine Chatelanaz, Franck Favre-Besse, Julien Beoletto, Mélanie Née, Manon Belhassen, Cinira Lefèvre, Gérard de Pouvourville

Read the Full Article on Journal of Comparative Effectiveness Research

Laura Dormer: Real-World Insights into Treatment and Costs in VWD from FORvWARD Study

Stay updated on all scientific advances with Hemostasis Today.